BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34140063)

  • 1. Canadian Stroke Best Practice Recommendations: Secondary Prevention of Stroke Update 2020.
    Gladstone DJ; Lindsay MP; Douketis J; Smith EE; Dowlatshahi D; Wein T; Bourgoin A; Cox J; Falconer JB; Graham BR; Labrie M; McDonald L; Mandzia J; Ngui D; Pageau P; Rodgerson A; Semchuk W; Tebbutt T; Tuchak C; van Gaal S; Villaluna K; Foley N; Coutts S; Mountain A; Gubitz G; Udell JA; McGuff R; Heran MKS; Lavoie P; Poppe AY;
    Can J Neurol Sci; 2022 May; 49(3):315-337. PubMed ID: 34140063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canadian stroke best practice recommendations: Secondary prevention of stroke, sixth edition practice guidelines, update 2017.
    Wein T; Lindsay MP; Côté R; Foley N; Berlingieri J; Bhogal S; Bourgoin A; Buck BH; Cox J; Davidson D; Dowlatshahi D; Douketis J; Falconer J; Field T; Gioia L; Gubitz G; Habert J; Jaspers S; Lum C; McNamara Morse D; Pageau P; Rafay M; Rodgerson A; Semchuk B; Sharma M; Shoamanesh A; Tamayo A; Smitko E; Gladstone DJ;
    Int J Stroke; 2018 Jun; 13(4):420-443. PubMed ID: 29171361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.
    Li J; Liu J; Liu M; Zhang S; Hao Z; Zhang J; Zhang C
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009938. PubMed ID: 26346232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canadian Stroke Best Practice Recommendations: Acute Stroke Management, 7
    Heran M; Lindsay P; Gubitz G; Yu A; Ganesh A; Lund R; Arsenault S; Bickford D; Derbyshire D; Doucette S; Ghrooda E; Harris D; Kanya-Forstner N; Kaplovitch E; Liederman Z; Martiniuk S; McClelland M; Milot G; Minuk J; Otto E; Perry J; Schlamp R; Tampieri D; van Adel B; Volders D; Whelan R; Yip S; Foley N; Smith EE; Dowlatshahi D; Mountain A; Hill MD; Martin C; Shamy M
    Can J Neurol Sci; 2024 Jan; 51(1):1-31. PubMed ID: 36529857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Secondary stroke prevention after TIA or ischemic stroke].
    Diener HC; Nickenig G
    Herz; 2021 Jun; 46(3):293-302. PubMed ID: 33914089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of patent foramen ovale closure versus medical therapy for prevention of recurrent ischemic neurological events: Impact of medication type.
    Pan X; Xu L; Zhou C; Zhang Z; Sun H
    Medicine (Baltimore); 2021 Jun; 100(25):e26473. PubMed ID: 34160457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
    Kernan WN; Ovbiagele B; Black HR; Bravata DM; Chimowitz MI; Ezekowitz MD; Fang MC; Fisher M; Furie KL; Heck DV; Johnston SC; Kasner SE; Kittner SJ; Mitchell PH; Rich MW; Richardson D; Schwamm LH; Wilson JA;
    Stroke; 2014 Jul; 45(7):2160-236. PubMed ID: 24788967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack.
    Saxena R; Koudstaal P
    Cochrane Database Syst Rev; 2004 Oct; (4):CD000187. PubMed ID: 15494992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canadian Stroke Best Practice Recommendations for Acute Stroke Management: Prehospital, Emergency Department, and Acute Inpatient Stroke Care, 6th Edition, Update 2018.
    Boulanger JM; Lindsay MP; Gubitz G; Smith EE; Stotts G; Foley N; Bhogal S; Boyle K; Braun L; Goddard T; Heran M; Kanya-Forster N; Lang E; Lavoie P; McClelland M; O'Kelly C; Pageau P; Pettersen J; Purvis H; Shamy M; Tampieri D; vanAdel B; Verbeek R; Blacquiere D; Casaubon L; Ferguson D; Hegedus Y; Jacquin GJ; Kelly M; Kamal N; Linkewich B; Lum C; Mann B; Milot G; Newcommon N; Poirier P; Simpkin W; Snieder E; Trivedi A; Whelan R; Eustace M; Smitko E; Butcher K
    Int J Stroke; 2018 Dec; 13(9):949-984. PubMed ID: 30021503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing strokes: the assessment and management of people with transient ischaemic attack.
    Gommans J; Barber PA; Fink J
    N Z Med J; 2009 Apr; 122(1293):3556. PubMed ID: 19448791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canadian Stroke Best Practice Recommendations: secondary prevention of stroke guidelines, update 2014.
    Coutts SB; Wein TH; Lindsay MP; Buck B; Cote R; Ellis P; Foley N; Hill MD; Jaspers S; Jin AY; Kwiatkowski B; MacPhail C; McNamara-Morse D; McMurtry MS; Mysak T; Pipe A; Silver K; Smith EE; Gubitz G;
    Int J Stroke; 2015 Apr; 10(3):282-91. PubMed ID: 25535808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks.
    Koudstaal PJ
    Cochrane Database Syst Rev; 2000; (2):CD000187. PubMed ID: 10796315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke: Updated Meta-Analysis of Randomized Clinical Trials.
    Vaduganathan M; Qamar A; Gupta A; Bajaj N; Golwala HB; Pandey A; Bhatt DL
    Am J Med; 2018 May; 131(5):575-577. PubMed ID: 29229471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2014 Chinese guidelines for secondary prevention of ischemic stroke and transient ischemic attack.
    Wang Y; Liu M; Pu C
    Int J Stroke; 2017 Apr; 12(3):302-320. PubMed ID: 28381199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks.
    Aguilar MI; Hart R; Pearce LA
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006186. PubMed ID: 17636831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Several heart conditions are related to increased risk of ischemic stroke and TIA].
    G Lindgren A; Wester P
    Lakartidningen; 2023 Sep; 120():. PubMed ID: 37665256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Update on antithrombotic secondary prevention of ischemic stroke].
    Köhrmann M; Kleinschnitz C
    Nervenarzt; 2019 Oct; 90(10):995-1004. PubMed ID: 31560112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary stroke prevention with apixaban in nonvalvular atrial fibrillation: A subgroup analysis of the STANDARD study.
    Yasaka M; Umeyama M; Kataoka H; Inoue H
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105034. PubMed ID: 32807446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Underutilization of Ambulatory ECG Monitoring After Stroke and Transient Ischemic Attack: Missed Opportunities for Atrial Fibrillation Detection.
    Edwards JD; Kapral MK; Fang J; Saposnik G; Gladstone DJ;
    Stroke; 2016 Aug; 47(8):1982-9. PubMed ID: 27406109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.